Fifth joint meeting of J-CaP and CaPSURE: Advancing the global understanding of prostate cancer and its management

Hideyuki Akaza, Peter Carroll, Matthew R. Cooperberg, Shiro Hinotsu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This report summarizes the presentations and discussions that took place at the Fifth Joint Meeting of J-CaP and CaPSURE held in Tokyo, Japan, in July 2011. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data on prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since its inception, the initiative has reviewed a wide range of topics and generated valuable data on the patterns of prostate cancer treatment and patient outcomes in the two geographical regions. The objectives of this 5th Joint Meeting were to provide an update on the current status of the J-CaP and CaPSURE databases, and also to discuss perspectives from a range of other Asian countries-Japan, China, Indonesia and Korea-on the use of androgen deprivation therapy for prostate cancer. The collaborators recognize that large databases, such as J-CaP and CaPSURE, provide valuable 'real-world' information, to complement data from clinical trials, which can help to advance the clinical management of prostate cancer patients worldwide. It is anticipated that in the near future, the Joint Initiative will expand globally to include patient registries from other countries so that best practice can be shared and regional differences in patients, treatments and outcomes can be explored.

Original languageEnglish
Article numberhyr194
Pages (from-to)226-236
Number of pages11
JournalJapanese Journal of Clinical Oncology
Volume42
Issue number3
DOIs
Publication statusPublished - Mar 2012
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Japan
Databases
Indonesia
Tokyo
Korea
Practice Guidelines
Androgens
Registries
China
Clinical Trials
Therapeutics

Keywords

  • Androgen deprivation therapy
  • J-CAPRA
  • Overall survival
  • Prostate cancer
  • Risk stratification

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

Fifth joint meeting of J-CaP and CaPSURE : Advancing the global understanding of prostate cancer and its management. / Akaza, Hideyuki; Carroll, Peter; Cooperberg, Matthew R.; Hinotsu, Shiro.

In: Japanese Journal of Clinical Oncology, Vol. 42, No. 3, hyr194, 03.2012, p. 226-236.

Research output: Contribution to journalArticle

Akaza, Hideyuki ; Carroll, Peter ; Cooperberg, Matthew R. ; Hinotsu, Shiro. / Fifth joint meeting of J-CaP and CaPSURE : Advancing the global understanding of prostate cancer and its management. In: Japanese Journal of Clinical Oncology. 2012 ; Vol. 42, No. 3. pp. 226-236.
@article{cbfb5003874847c99d8dc5bacd251390,
title = "Fifth joint meeting of J-CaP and CaPSURE: Advancing the global understanding of prostate cancer and its management",
abstract = "This report summarizes the presentations and discussions that took place at the Fifth Joint Meeting of J-CaP and CaPSURE held in Tokyo, Japan, in July 2011. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data on prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since its inception, the initiative has reviewed a wide range of topics and generated valuable data on the patterns of prostate cancer treatment and patient outcomes in the two geographical regions. The objectives of this 5th Joint Meeting were to provide an update on the current status of the J-CaP and CaPSURE databases, and also to discuss perspectives from a range of other Asian countries-Japan, China, Indonesia and Korea-on the use of androgen deprivation therapy for prostate cancer. The collaborators recognize that large databases, such as J-CaP and CaPSURE, provide valuable 'real-world' information, to complement data from clinical trials, which can help to advance the clinical management of prostate cancer patients worldwide. It is anticipated that in the near future, the Joint Initiative will expand globally to include patient registries from other countries so that best practice can be shared and regional differences in patients, treatments and outcomes can be explored.",
keywords = "Androgen deprivation therapy, J-CAPRA, Overall survival, Prostate cancer, Risk stratification",
author = "Hideyuki Akaza and Peter Carroll and Cooperberg, {Matthew R.} and Shiro Hinotsu",
year = "2012",
month = "3",
doi = "10.1093/jjco/hyr194",
language = "English",
volume = "42",
pages = "226--236",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Fifth joint meeting of J-CaP and CaPSURE

T2 - Advancing the global understanding of prostate cancer and its management

AU - Akaza, Hideyuki

AU - Carroll, Peter

AU - Cooperberg, Matthew R.

AU - Hinotsu, Shiro

PY - 2012/3

Y1 - 2012/3

N2 - This report summarizes the presentations and discussions that took place at the Fifth Joint Meeting of J-CaP and CaPSURE held in Tokyo, Japan, in July 2011. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data on prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since its inception, the initiative has reviewed a wide range of topics and generated valuable data on the patterns of prostate cancer treatment and patient outcomes in the two geographical regions. The objectives of this 5th Joint Meeting were to provide an update on the current status of the J-CaP and CaPSURE databases, and also to discuss perspectives from a range of other Asian countries-Japan, China, Indonesia and Korea-on the use of androgen deprivation therapy for prostate cancer. The collaborators recognize that large databases, such as J-CaP and CaPSURE, provide valuable 'real-world' information, to complement data from clinical trials, which can help to advance the clinical management of prostate cancer patients worldwide. It is anticipated that in the near future, the Joint Initiative will expand globally to include patient registries from other countries so that best practice can be shared and regional differences in patients, treatments and outcomes can be explored.

AB - This report summarizes the presentations and discussions that took place at the Fifth Joint Meeting of J-CaP and CaPSURE held in Tokyo, Japan, in July 2011. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data on prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since its inception, the initiative has reviewed a wide range of topics and generated valuable data on the patterns of prostate cancer treatment and patient outcomes in the two geographical regions. The objectives of this 5th Joint Meeting were to provide an update on the current status of the J-CaP and CaPSURE databases, and also to discuss perspectives from a range of other Asian countries-Japan, China, Indonesia and Korea-on the use of androgen deprivation therapy for prostate cancer. The collaborators recognize that large databases, such as J-CaP and CaPSURE, provide valuable 'real-world' information, to complement data from clinical trials, which can help to advance the clinical management of prostate cancer patients worldwide. It is anticipated that in the near future, the Joint Initiative will expand globally to include patient registries from other countries so that best practice can be shared and regional differences in patients, treatments and outcomes can be explored.

KW - Androgen deprivation therapy

KW - J-CAPRA

KW - Overall survival

KW - Prostate cancer

KW - Risk stratification

UR - http://www.scopus.com/inward/record.url?scp=84857946027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857946027&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyr194

DO - 10.1093/jjco/hyr194

M3 - Article

C2 - 22217576

AN - SCOPUS:84857946027

VL - 42

SP - 226

EP - 236

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 3

M1 - hyr194

ER -